- Home
- NRSN vs NYC Comparison
NRSN vs NYC Comparison
Compare NRSN & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRSN | NYC |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Israel | United States |
| Employees | 16 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 24.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | NRSN | NYC |
|---|---|---|
| Price | $0.60 | $8.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 160.7K | 70.1K |
| Earning Date | 03-31-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.28 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $56.73 |
| Revenue Next Year | $583.67 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.58 | $7.00 |
| 52 Week High | $2.09 | $14.00 |
Technical Indicators
Market Signals| Indicator | NRSN | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 27.20 | 45.05 |
| Support Level | N/A | $7.10 |
| Resistance Level | $0.74 | $8.28 |
| Average True Range (ATR) | 0.05 | 0.41 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 13.19 | 11.40 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.